Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biofrontera Inc

0.6880
-0.0235-3.30%
Post-market: 0.6879-0.0001-0.01%17:35 EDT
Volume:219.61K
Turnover:147.29K
Market Cap:6.50M
PE:-0.41
High:0.7000
Open:0.6600
Low:0.6401
Close:0.7115
Loading ...

Biofrontera Inc - Expects Last-Patient-Out in Q3 2025 for Ameluz Trial

THOMSON REUTERS
·
16 May

Biofrontera Inc. Faces Nasdaq Delisting Threat Due to Non-Compliance with Minimum Bid Price Rule

Reuters
·
15 May

Biofrontera Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
14 May

Biofrontera AG’s Earnings Call Highlights Growth and Strategic Advances

TIPRANKS
·
24 Apr

Biofrontera AG Prepares to Release 2024 Financial Report

TIPRANKS
·
17 Apr

Biofrontera AG Reports 2024 Financial Results and Strategic Growth Plans

TIPRANKS
·
15 Apr

Biofrontera AG Meets 2024 Forecasts and Outlines 2025 Financial Expectations

TIPRANKS
·
15 Apr

Biofrontera’s Growth Potential: Buy Rating Backed by FDA Approval and Positive Phase 3 Results

TIPRANKS
·
25 Mar

Biofrontera Inc. Reports Record Sales and Strategic Advances

TIPRANKS
·
25 Mar

Biofrontera Full Year 2024 Earnings: Misses Expectations

Simply Wall St.
·
22 Mar

Biofrontera Inc (BFRI) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amidst Financial ...

GuruFocus.com
·
22 Mar

Q4 2024 Biofrontera Inc Earnings Call

Thomson Reuters StreetEvents
·
22 Mar

Biofrontera Inc. Reports Record Revenue Growth in 2024

TIPRANKS
·
22 Mar

Biofrontera Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
21 Mar

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update

THOMSON REUTERS
·
21 Mar

Biofrontera Q4 Revenue USD 12.6 Million

THOMSON REUTERS
·
21 Mar

Biofrontera Q4 Adjusted Ebitda USD -1.4 Million

THOMSON REUTERS
·
21 Mar

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update

GlobeNewswire
·
21 Mar

Biofrontera FY 2024 GAAP EPS $(3.22) May Not Be Comparable To $(0.85) Estimate, Sales $37.32M Miss $47.06M Estimate

Benzinga
·
21 Mar

Biofrontera Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
19 Mar